Health · Pharma & Biotech · 1 hr ago

Five drugmakers say they will not start trials at some China sites

Five drugmakers say they will not start trials at some China sites

Five major drugmakers told a US House committee they would not start new clinical studies at sites linked to China’s military.

The companies are Merck, Eli Lilly, AbbVie, Pfizer and Bristol Myers Squibb.

They also said they would not open new trial sites in Xinjiang, a region of China.

The House Select Committee on China began investigating the companies last June over concerns about intellectual property, military links and ethical standards at trial sites.

The committee also raised concerns about possible security risks.

The companies’ commitments apply to new studies, not existing trials.

The committee’s investigation is ongoing, and the companies’ letters to it disclosed their plans.

1 source

Related